Duncan Williams Reiterates Buy and PT of $80 on Varian Medical

Emily Austin , Benzinga Staff Writer

July 27, 2011 9:15am Comments

Duncan Williams reiterated its Buy rating on Varian Medical (NASDAQ: VAR). At the same time, the rating agency left its price target on the company's stock unchanged at $80. On Tuesday, VAR closed the day at $68.57.

View Comments and Join the Discussion!

View the discussion thread.

Posted-In: Duncan Williams Reiteration Analyst Ratings

Need analyst data?
Click here to see licensing options.

Latest Ratings

Stock	Firm	Action	PT
SEDG	B of A Securities	Maintains	411.0
PTLO	Piper Sandler	Maintains	28.0
AOUT	Lake Street	Maintains	26.0
RAPT	Piper Sandler	Maintains	52.0
OCX	Lake Street	Maintains	6.0

View the Latest Analytics Ratings

1	QQQ, XLK: This Nasdaq 100 Signal Last Flashed In 1999—What Came Next Was Insane
2	$BTC, MEDP: Lockheed, General Motors Tumble, Gold Hits 1-Month Highs: What...
3	HON: Honeywell Lifts Outlook As Transformation Picks Up Speed
4	SPY, QQQ: Federal Reserve Rates 'Justified' Despite...
5	KO: Coke's Sweet Switch: Cane Sugar Beverage, Fa...
6	$BTC, TSLA: Tesla Q2 Earnings Highlights: Revenue A...
7	GTX, TTE: Earnings Scheduled For July 24, 2025

1	MASI: $1000 Invested In This Stock 15 Years Ago Would Be Worth This Much Today
2	GOOG, GOOGL: Google Stock Roars As Analysts Race To Raise Price Targets
3	DJT, $BTC: Trump Media (DJT) Stock Pulls Back, Consolidating Recent...
4	GSK: GSK's Blood Cancer Drug Review Extended As FDA S...
5	A New Obesity Contender From China Targeting Same Rec...
6	LKQ: LKQ Shares Crash To 52-Week Low On Slashed Outlook
7	China's New Investment Playbook: VCs Chase Cr...

Market Overview

Tickers

Articles

Keywords

Duncan Williams Reiterates Buy and PT of $80 on Varian Medical

Related Articles (VAR)

Latest Ratings